Showing results (21-30 of 361) with videos related to
Sort By:
Pageof 37
Clinical Biochemistry|January 29, 2008
Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancerGeorgios Pampalakis, Andreas Scorilas, Georgia SotiropoulouBiological Chemistry|February 5, 2010
KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantroneKonstantinos Mavridis, Maroulio Talieri, Andreas ScorilasBiological Chemistry|November 30, 2006
Prognostic significance of the expression of SR-A1, encoding a novel SR-related CTD-associated factor, in breast cancerTheoni Leoutsakou, Maroulio Talieri, Andreas ScorilasExpert Review of Molecular Diagnostics|October 20, 2018
miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancersKonstantina Panoutsopoulou, Margaritis Avgeris, Andreas ScorilasTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 23, 2012
Significant alterations in the expression pattern of kallikrein-related peptidase genes KLK4, KLK5 and KLK14 after treatment of breast cancer cells with the chemotherapeutic agents epirubicin, docetaxel and methotrexateGeorgia Papachristopoulou, Maroulio Talieri, Andreas ScorilasTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 6, 2012
The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agentsDimitra Florou, Konstantinos Mavridis, Andreas ScorilasThe Prostate|April 27, 2011
Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significanceMargaritis Avgeris, Konstantinos Stravodimos, Andreas ScorilasBiological Chemistry|April 17, 2012
Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevanceMargaritis Avgeris, Konstantinos Mavridis, Andreas ScorilasBiological Chemistry|August 26, 2014
Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patientsMargaritis Avgeris, Konstantinos Stravodimos, Andreas ScorilasExpert Opinion on Therapeutic Targets|February 28, 2014
Targeting kallikrein-related peptidases in prostate cancerKonstantinos Mavridis, Margaritis Avgeris, Andreas ScorilasPageof 37